Your Challenges Require Smart Solutions:

Pharmacelsus

Market-leading early stage contract research organisation

Pharmacelsus, Germany´s market-leading early stage CRO, plans, organizes and realizes customized preclinical studies for more than 20 years. Our assays meet national and international regulatory demands while using our unique consultative approach to serve more than 120+ satisfied customers who rely on our expertise, experience and passion for science.

Hit–to–Lead & Lead Optimisation

The Pharmacelsus portfolio covers the complete drug discovery and development testing program for small molecules and peptides in vitro, in vivo, ex vivo as well as G(C)LP and non-GLP bioanalysis. Structural, physicochemical and functional characterization of Biopharmaceuticals (e.g. Antibodies, ADCs, etc.) complements our comprehensive portfolio.

GBA Group Pharma

Preclinical Services

The experienced and highly committed Pharmacelsus team offers a comprehensive range of services in the following areas …

GBA Group Pharma Sites

Preclinical Services


Science Park 2
66123 Saarbrücken
Germany

Preclinical Services

Pharmacelsus GmbH

Science Park 2
66123 Saarbrücken
Germany

Tel. +49 681 3946 - 7510
Fax +49 681 3946 - 7511
info@pharmacelsus.de

Contact
Member of GBA Group Pharma since 2017.

© 2020 GBA Group